Novo Nordisk | NVO - Ebit

Stock Price
41.17
Daily Change
-0.01 -0.02%
Monthly
16.70%
Yearly
-36.80%
Q2 Forecast
39.20

Novo Nordisk reported DKK5.18B in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Bausch Health Companies USD 719M 2M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Zoetis USD 835M 140M Dec/2025